NCT01286987 2019-01-10Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPfizerPhase 1 Completed113 enrolled 39 charts
NCT01444456 2017-03-20Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaAmgenCompleted1,262 enrolled 14 charts
NCT00966277 2016-12-12Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsM.D. Anderson Cancer CenterPhase 4 Completed87 enrolled 9 charts